Cargando…

Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss

BACKGROUND: Loss of pancreatic insulin-secreting β-cells due to metabolic or autoimmune damage leads to the development of diabetes. The discovery that α-cells can be efficiently reprogrammed into insulin-secreting cells in mice and humans has opened promising avenues for innovative diabetes therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oropeza, Daniel, Cigliola, Valentina, Romero, Agustín, Chera, Simona, Rodríguez-Seguí, Santiago A., Herrera, Pedro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330016/
https://www.ncbi.nlm.nih.gov/pubmed/34340653
http://dx.doi.org/10.1186/s12864-021-07812-x
_version_ 1783732614322978816
author Oropeza, Daniel
Cigliola, Valentina
Romero, Agustín
Chera, Simona
Rodríguez-Seguí, Santiago A.
Herrera, Pedro L.
author_facet Oropeza, Daniel
Cigliola, Valentina
Romero, Agustín
Chera, Simona
Rodríguez-Seguí, Santiago A.
Herrera, Pedro L.
author_sort Oropeza, Daniel
collection PubMed
description BACKGROUND: Loss of pancreatic insulin-secreting β-cells due to metabolic or autoimmune damage leads to the development of diabetes. The discovery that α-cells can be efficiently reprogrammed into insulin-secreting cells in mice and humans has opened promising avenues for innovative diabetes therapies. β-cell loss triggers spontaneous reprogramming of only 1–2% of α-cells, limiting the extent of regeneration. Most α-cells are refractory to conversion and their global transcriptomic response to severe β-cell loss as well as the mechanisms opposing their reprogramming into insulin producers are largely unknown. Here, we performed RNA-seq on FAC-sorted α-cells to characterize their global transcriptional responses at different time points after massive β-cell ablation. RESULTS: Our results show that α-cells undergo stage-specific transcriptional changes 5- and 15-days post-diphtheria toxin (DT)-mediated β-cell ablation. At 5 days, α-cells transiently upregulate various genes associated with interferon signaling and proliferation, including Interferon Induced Protein with Tetratricopeptide Repeats 3 (Ifit3). Subsequently, at 15 days post β-cell ablation, α-cells undergo a transient downregulation of genes from several pathways including Insulin receptor, mTOR and MET signaling. CONCLUSIONS: The results presented here pinpoint novel markers discriminating α-cells at different stages after acute β-cell loss, and highlight additional signaling pathways that are modulated in α-cells in this context. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07812-x.
format Online
Article
Text
id pubmed-8330016
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83300162021-08-03 Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss Oropeza, Daniel Cigliola, Valentina Romero, Agustín Chera, Simona Rodríguez-Seguí, Santiago A. Herrera, Pedro L. BMC Genomics Research BACKGROUND: Loss of pancreatic insulin-secreting β-cells due to metabolic or autoimmune damage leads to the development of diabetes. The discovery that α-cells can be efficiently reprogrammed into insulin-secreting cells in mice and humans has opened promising avenues for innovative diabetes therapies. β-cell loss triggers spontaneous reprogramming of only 1–2% of α-cells, limiting the extent of regeneration. Most α-cells are refractory to conversion and their global transcriptomic response to severe β-cell loss as well as the mechanisms opposing their reprogramming into insulin producers are largely unknown. Here, we performed RNA-seq on FAC-sorted α-cells to characterize their global transcriptional responses at different time points after massive β-cell ablation. RESULTS: Our results show that α-cells undergo stage-specific transcriptional changes 5- and 15-days post-diphtheria toxin (DT)-mediated β-cell ablation. At 5 days, α-cells transiently upregulate various genes associated with interferon signaling and proliferation, including Interferon Induced Protein with Tetratricopeptide Repeats 3 (Ifit3). Subsequently, at 15 days post β-cell ablation, α-cells undergo a transient downregulation of genes from several pathways including Insulin receptor, mTOR and MET signaling. CONCLUSIONS: The results presented here pinpoint novel markers discriminating α-cells at different stages after acute β-cell loss, and highlight additional signaling pathways that are modulated in α-cells in this context. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07812-x. BioMed Central 2021-08-02 /pmc/articles/PMC8330016/ /pubmed/34340653 http://dx.doi.org/10.1186/s12864-021-07812-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Oropeza, Daniel
Cigliola, Valentina
Romero, Agustín
Chera, Simona
Rodríguez-Seguí, Santiago A.
Herrera, Pedro L.
Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title_full Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title_fullStr Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title_full_unstemmed Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title_short Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
title_sort stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330016/
https://www.ncbi.nlm.nih.gov/pubmed/34340653
http://dx.doi.org/10.1186/s12864-021-07812-x
work_keys_str_mv AT oropezadaniel stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss
AT cigliolavalentina stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss
AT romeroagustin stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss
AT cherasimona stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss
AT rodriguezseguisantiagoa stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss
AT herrerapedrol stagespecifictranscriptomicchangesinpancreaticacellsaftermassivebcellloss